Cognetivity Neurosciences Ltd.

OTC: CGNSF · Healthcare · Medical - Healthcare Information Services

Canadian filerHQ Vancouver, BCReports USD

#1084 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 42

v0.1 · 5/100 weight · pillars only

↑ workforce scale, disclosure history · ↓ operating margin, net margin

Methodology →

Revenue TTM

$73.4k

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$5.7M

Employees

2,500

Market cap

$9.0k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$34.7k45.4k CAD2022

Net income-$5.7M-7.4M CAD2022

Operating income-$4.8M-6.3M CAD2022

Total assets$2.1M2.8M CAD2022

Liabilities$9.5M12.7M CAD2022

Equity-$7.4M-9.9M CAD2022

Revenue trend

FY2016 – FY2022 · USD

FY16

FY17

FY18

FY19

FY20

FY21

$34.7k

FY22

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Cognetivity Neurosciences Ltd. booked $34.7k in FY2022 revenue — among the slowest-growing Healthcare companies we track, at a -16386.3% net margin.

Peers · Healthcare

Infinity Pharmaceuticals, Inc.——RenovaCare, Inc.——Capital Group Holdings, Inc.——Medite Cancer Diagnostics, Inc.——

Key facts

CEOSina Habibi

SectorHealthcare

IndustryMedical - Healthcare Information Services

HeadquartersVancouver, BC

ExchangeOTC: CGNSF

Employees2,500

IPO date2021-01-08

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.